Interference with HMGB1 Inhibits Neuronal Ferroptosis Following Spinal Cord Injury through Targeting ACSL4
Neurochemical Research · 2026-06 · 51 (3)
DOI: 10.1007/s11064-026-04798-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurochemical Research, online erschienen am 28.05.2026. Verfasst von Zhiwu Wu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Ganzhou People's Hospital, Ganzhou Hospital-Nanfang Hospital, Southern Medical University, Ganzhou, 341000, China. Hauptthemen laut MEDLINE: HMGB1 Protein, Spinal Cord Injuries, Ferroptosis, Coenzyme A Ligases. Die Arbeit nennt 44 Literaturangaben. Gefördert von: Science and Technology Plan project of Ganzhou City, Natural Science Foundation of Jiangxi Province, Research Project of the Jiangxi Provincial Administration of Traditional Chinese Medicine.
Abstract (Originalsprache)
This study aimed to investigate the regulatory role of High-mobility group box 1 (HMGB1) in neuronal ferroptosis following spinal cord injury (SCI) and its underlying mechanisms. Iron ion deposition, malondialdehyde (MDA) and glutathione (GSH) levels, as well as the expressions of HMGB1, acyl-CoA synthetase long-chain family member 4 (ACSL4), solute carrier family 7 member 11 (SLC7A11), and glutathione peroxidase 4 (GPX4) in spinal cord tissue of SCI rats were measured at 24 h, 72 h and 1 week post-injury. Then, an in vitro neuronal ferroptosis model was established and neuronal cells were transfected with lentiviral vectors for HMGB1 interference or ACSL4 overexpression. Iron ion levels, MDA content, GSH activity, and the expressions of HMGB1, ACSL4, SLC7A11 and GPX4 were measured. And the interaction between HMGB1 and ACSL4 was assessed. Finally, SCI rats were administered the HMGB1 inhibitor glycyrrhizic acid (GA) and the effects GA on the iron ion deposition, MDA and SOD levels, as well as the expressions of HMGB1, ACSL4, SLC7A11 and GPX4 in spinal cord tissues were evaluated. SCI induced time-dependent iron deposition, increased MDA, HMGB1, and ACSL4, and decreased GSH, GPX4, and SLC7A11. The administration of GA in SCI rats significantly reduces iron ion deposition, decreases the levels of MDA, HMGB1 and ACSL4, and increases the levels of GSH, GPX4, and SLC7A11. Furthermore, cellular-level results demonstrated that interfering with HMGB1 attenuated ferroptosis in rat spinal cord neurons by suppressing ACSL4. Targeted suppression of ACSL4 expression through interference with HMGB1 inhibits neuronal ferroptosis in SCI rats.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, Ganzhou People's Hospital, Ganzhou Hospital-Nanfang Hospital, Southern Medical University, Ganzhou, 341000, China.
- Department of Neurosurgery, Ganzhou People's Hospital, Ganzhou Hospital-Nanfang Hospital, Southern Medical University, Ganzhou, 341000, China. huangqianliang2023@163.com.
Förderung
- Science and Technology Plan project of Ganzhou City
- Natural Science Foundation of Jiangxi Province
- Research Project of the Jiangxi Provincial Administration of Traditional Chinese Medicine
Zitieren
APA
Wu, Z., Zhong, Q., Li, T., Yuan, H., Zeng, T., Zhang, J., Feng, K., Ye, X., Jiang, Q., & Huang, Q. (2026). Interference with HMGB1 Inhibits Neuronal Ferroptosis Following Spinal Cord Injury through Targeting ACSL4. Neurochemical Research, 51(3). https://doi.org/10.1007/s11064-026-04798-4
Vancouver
Wu Z, Zhong Q, Li T, Yuan H, Zeng T, Zhang J, et al. Interference with HMGB1 Inhibits Neuronal Ferroptosis Following Spinal Cord Injury through Targeting ACSL4. Neurochemical Research. 2026;51(3). doi:10.1007/s11064-026-04798-4
BibTeX
@article{Wu2026,
author = {Wu, Zhiwu and Zhong, Qinglin and Li, Tao and Yuan, Helan and Zeng, Tianxiang and Zhang, Jinshi and Feng, Kaiming and Ye, Xinyun and Jiang, Qiuhua and Huang, Qianliang},
title = {Interference with HMGB1 Inhibits Neuronal Ferroptosis Following Spinal Cord Injury through Targeting ACSL4},
journal = {Neurochemical Research},
year = {2026},
volume = {51},
number = {3},
doi = {10.1007/s11064-026-04798-4}
}
EUVIMED